Harvard Business Review

MAY 5, 2016

But peruse some of the recent headlines about Iran , and you might wonder whether the market’s potential was overstated. However, despite a weakened economy, political tensions, market uncertainty, and the lingering effects of sanctions, Iran remains an important opportunity for multinationals in emerging markets.

Tourism 8

Tourism Banking Due Diligence Hotels 8

Harvard Business Review

JANUARY 5, 2018

For example, in 2009 professors Brian Becker, Mark Huselid, and Richard Beatty estimated that in most companies less than 15% of jobs are what they call strategic positions and said management should focus “disproportionate investments” on finding A players for those jobs. Connectors in the middle. High-potential future leaders.

McKinsey 8

McKinsey Human Resources Reputation Brand 8

Harvard Business Review

OCTOBER 26, 2015

A recent USC study shows that across multiple and diverse markets, industries are 25% more likely to be “highly concentrated” than they were 20 years ago. Yet at the same time, America’s largest companies are more than twice as likely to lose market share than in 1980. corporate consolidation.

Competitive Advantage 8

Competitive Advantage Pharmaceuticals Industry Trends 8

Harvard Business Review

DECEMBER 29, 2015

Today, the International Diabetes Federation (IDF) estimates that 415 million people, or about one in every 11, are living with the condition; in 2015, 28 million more adults have it than in 2014. When cities are planned, managed, and governed well, they can be engines of prosperity and greater personal well-being.

Health Care 8

Health Care NGO Pharmaceuticals Globalization 8

Strategy Driven

OCTOBER 10, 2016

As reaffirmed in Gartner’s 2015 report, How to Get Your Customer Service Employees to Care About the Customer , research shows “high levels of employee engagement contribute to higher levels of customer satisfaction.” CJ Stafford is president of Stafford Communications Group Inc.,

Strategy 50

Strategy Pharmaceuticals Learning-by-Doing Outsourcing 50

Harvard Business Review

OCTOBER 27, 2015

In most companies, marketers are in charge of assessing the competition. Because of this, close to 60 percent of all competitive intelligence professionals report to marketing. Yet the majority of marketers fail to use their competition analysts strategically, instead using them to gather more “recon” data.

Marketing 8

Marketing Competitive Intelligence Porter How To 8

Harvard Business Review

SEPTEMBER 4, 2015

We’ve found that CEOs of big pharmaceutical companies, for example, are more likely to have a background as company lawyers, salespeople, or finance managers, than one in medicine or pharmaceutical R&D. Pharmaceuticals. The data captured a 20-year period, from 1995 to 2014. Overall, it is a messy picture.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

JUNE 24, 2015

In this adaptation from the new book, Your Strategy Needs a Strategy (HBR Press, 2015), BCG strategy experts make sense of the all the different, and competing, approaches to strategy: Which strategy is right for your business? In a visionary setting, firms win by being the first to create a new market or to disrupt an existing one.

Strategy 8

Strategy Competitive Advantage Environment Execution 8

Harvard Business Review

MAY 25, 2017

From 2015 to 2016, investors poured more than $8 billion into funding these tools. More than 3,000 apps are now available to help manage diabetes alone. The pipeline for new drugs is bursting, and new devices and tools in the rapidly emerging digital health space will come to market more quickly.

Health Care 9

Health Care Trends Venture Funding Technology 9

Harvard Business Review

JULY 6, 2016

For 78-year-old Tony, 3,4 DAP — which can be obtained at low cost from compounding pharmacies or for free through a compassionate-use program supported by a small privately held company, Jacobus Pharmaceuticals — is a lifesaver. Pharmaceutical companies traditionally invest heavily in research and development.

Price 15

Price Pharmaceuticals Company Health Care 15

Harvard Business Review

APRIL 6, 2017

I help the University of Utah hospital system manage its drug budgets and medication use policies, and in 2015 I got sticker shock. The 1984 Drug Price Competition and Patent Term Restoration Act gave pharmaceutical companies exclusive protections for innovating a new drug. Problems with generic drug makers.

System 13

System Pharmaceuticals Company Sample 13

Harvard Business Review

JANUARY 4, 2017

There are similar stories in the electronics industry, pet food, pharmaceuticals, and even national security. We now have three years’ worth of reports in hand, and our analysis , published in the Academy of Management Journal, shows that giant multinational corporations often have little idea where their raw materials come from.

Supply Chain 9

Supply Chain Productivity Products Company 9